Wall Street Journal. Europe 2001 Vanessa. Fuhrmans |
Title | Subject | Authors |
Allianz-Dresdner deal may trigger business revolution. | Business, international | Christopher Rhoads, Vanessa Fuhrmans, Marcus Walker |
Aventis Expects Existing Drugs To Fuel Growth.(Aventis S.A. reports loss of $147 mn in Euro dollars for 2000) | Business, international | Vanessa Fuhrmans, Gautum Naik |
BASF warns 1st-half growth will be 'somewhat subdued.' | Business, international | Vanessa Fuhrmans |
Baxter to purchase oncology business from Degussa.(Firm makes its first big push into cancer-treatment market.) | Business, international | Vanessa Fuhrmans |
Bayer and CuraGen will study, develop small-molecule drugs. | Business, international | Vanessa Fuhrmans, Scott Hensley |
Bayer emerges as front-runner for Aventis unit. | Business, international | Anita Raghavan, Vanessa Fuhrmans |
Bayer plans to buy unit from Aventis for 5.5 billion euros. | Business, international | Vanessa Fuhrmans |
Bayer's operating earnings fell 45% in second quarter.(Company to cut 1,800 jobs and close 18 chemical plants.) | Business, international | Vanessa Fuhrmans |
Bayer to sell Agfa-Gevaert stake to shed nonstrategic activities. | Business, international | Vanessa Fuhrmans |
Drug makers' results offer hope, but investors demur.(GlaxoSmithKline, Serono post healthy second-quarter earnings.) | Business, international | Vanessa Fuhrmans |
European panel will review cholesterol-lowering drugs.(Decision comes a day after Baycol withdrawal.) | Business, international | Vanessa Fuhrmans |
Germany's bitter ethics debate.(embryonic stem cells debate in Germany) | Business, international | Vanessa Fuhrmans |
Lesson in alienation: How Bayer angered a captive market. | Business, international | Vanessa Fuhrmans |
Novartis buys 20% stake in Roche for C3.12 billion (Euro dollars). | Business, international | Vanessa Fuhrmans |
Roche and Decode make progress on gene findings.(Firms target schizophrenia, narrowing of arteries.) | Business, international | Vanessa Fuhrmans |
Roche, DeCODE set research pact. | Business, international | Vanessa Fuhrmans |
Roche fires its CFO over lack of chemistry. | Business, international | Vanessa Fuhrmans |
Roche posts 2% drop in drug sales. | Business, international | Vanessa Fuhrmans, Anita Greil |
Roche sees operating margin shrinking this year (Roche Holding AG). | Business, international | Vanessa Fuhrmans |
Roche weighs cost-cutting plan to boost ailing drug division. | Business, international | Vanessa Fuhrmans |
Roche will cut 3,000 jobs in pharmaceuticals division. | Business, international | Vanessa Fuhrmans |
Sulzer Ltd. chairman steps down, citing hostile takeover bid.(InCentive Capital's offer focuses criticism on roost.) | Business, international | Vanessa Fuhrmans, Anita Greil |
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.